Form 4 for ENTX Entera Bio Ltd.
Accepted 2026-01-02 00:00:00 ET · period of report 2026-01-01 · accession 0001178913-26-000015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-02 | 2026-01-01 | ENTX | Taitel Haya | Dir | A - Grant | $0.00 | +26.3K | 91.0K | +41% | $0 |
| D | 2026-01-02 | 2026-01-01 | ENTX | Taitel Haya | Dir | A - Grant | $0.00 | +33.5K | 33.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares, par value NIS 0.0000769 per share | 2026-01-01 | A | A | 26,329 | $0.00 | 90,979 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2026-01-01 | A | A | 33,505 | $0.00 | 33,505 | D | $1.94 · — to 2036-01-01 | 33,505 Ordinary Shares, par value NIS 0.0000769 per share | (F2) These options represent the Board's annual grant of options to directors of the Company. The options vest ratably on a quarterly basis over a one-year period that commenced on January 1, 2026. |